Text Message Intervention to Improve Adherence in Adolescents and Young Adults With Celiac Disease
NCT02458898 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2016-05-27
Summary
This is a prospective randomized controlled trial investigating the impact of educational bidirectional text message reminders on gluten free diet adherence among adolescents and young adults with celiac disease age 12-24. Participants will complete a series of online questionnaires assessing quality of life, patient activation, celiac symptoms, and self reported dietary adherence at the beginning and end of the study. Participants will also have their blood drawn to measure Tissue Transglutaminase IgA (TTG IgA) antibody and Deamidated Gliadin Peptide IgA (DGP IgA) at the beginning and end of the study. Lab draws can be done locally, and are at no cost to the participant. Patients are randomized to the intervention or control group based on enrollment TTG IgA. Intervention group receives 45 unique text messages over the 3 month study. A gift card is provided for participation in the study.
Conditions
Interventions
- BEHAVIORAL
-
Educational Text Message Reminders
45 unique text messages designed by the Stanford Pediatric Gastroenterology physicians and nutritionists
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Kelly B Haas, MD · Stanford Pediatric Gastroenterology
Study Design
- Allocation
- RANDOMIZED
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 24 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- United States
Study Locations
More Related Trials
-
Virtual Celiac Symptoms Study in Adults and Teenagers
NCT05309330 ·Status: COMPLETED
-
Dietary Intervention Using a Gluten-free App to Improve Tracking, Adherence, and Learning(DIGITAL) Study
NCT07192874 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Gluten Reduction and Risk of Celiac Disease
NCT04593888 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Behavioral Intervention for Celiac Disease
NCT05204446 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Support for Adolescents With Celiac Disease
NCT04533776 ·Status: COMPLETED ·Phase: NA
-
Treatment of Mild Enteropathy Celiac Disease
NCT00628823 ·Status: COMPLETED ·Phase: NA
-
Eating Behaviors in Children and Adolescents With/Without Celiac Disease
NCT07285512 ·Status: NOT_YET_RECRUITING
-
Gluten Ingestion Biomarkers in Patients w Gluten Sensitivity and Healthy Controls Peptides in Patients With Non-celiac Gluten Sensitivity and Healthy Patients: A Placebo-controlled Study
NCT02936297 ·Status: COMPLETED ·Phase: NA
-
Study to Assess the Efficacy of Larazotide Acetate for the Treatment of Celiac Disease
NCT00492960 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
NCT07298343 ·Status: RECRUITING ·Phase: PHASE2
-
Multicenter Study on the Toxicity of Gluten Traces in the Treatment of Celiac Disease
NCT00250146 ·Status: TERMINATED ·Phase: NA
-
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
NCT01396213 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Potential Allergenicity of New Soybean Varieties
NCT01950559 ·Status: TERMINATED
-
Influence of a Gluten Free Food Guide on Diet Quality and Adherence to the GFD in Youth With Celiac Disease
NCT06038344 ·Status: COMPLETED ·Phase: NA
-
Assessment of Coeliac Disease in Patients With Type 2 Diabetes
NCT06283264 ·Status: NOT_YET_RECRUITING
-
Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo
NCT02472704 ·Status: COMPLETED ·Phase: NA
-
Assessment of Adherence to Gluten Free Diet in Children and Adolescents by Detection of Gluten in Faecal Samples.
NCT03663309 ·Status: COMPLETED
-
Randomized, Double-Blind, Placebo-Controlled Study of Larazotide Acetate in Subjects With Active Celiac Disease
NCT00620451 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability Study of Larazotide Acetate in Celiac Disease Subjects
NCT00362856 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective, Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Symptomatic CD Patients
NCT04243551 ·Status: TERMINATED ·Phase: PHASE2
-
Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten Challenge
NCT03409796 ·Status: COMPLETED ·Phase: NA
-
Treatment of Screen-detected Celiac Disease
NCT01116505 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
NCT00889473 ·Status: COMPLETED ·Phase: PHASE2
-
Vedolizumab Induction May Prevent Celiac Enteritis
NCT02929316 ·Status: TERMINATED ·Phase: PHASE2
-
A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease
NCT06807463 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2